Prevalence and severity of anthelmintic resistance in ovine gastrointestinal nematodes in Australia (2009–2012)

OBJECTIVE: This study aimed to provide an indication of the prevalence and severity of anthelmintic resistance (AR) in the Australian sheep industry by compiling the results of faecal worm egg count reduction tests (FECRTs). METHODS: Government and private parasitology laboratories, pharmaceutical c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Australian veterinary journal 2014-12, Vol.92 (12), p.464-471
Hauptverfasser: Playford, MC, Smith, AN, Love, S, Besier, RB, Kluver, P, Bailey, JN
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:OBJECTIVE: This study aimed to provide an indication of the prevalence and severity of anthelmintic resistance (AR) in the Australian sheep industry by compiling the results of faecal worm egg count reduction tests (FECRTs). METHODS: Government and private parasitology laboratories, pharmaceutical companies and veterinarians known to have conducted FECRTs were asked to provide results that conformed to Australian and New Zealand standard diagnostic procedures. RESULTS: Data were available from a total of 390 tests, with larval differentiation conducted in 222 cases. Pooled results from all states for the macrocyclic lactone (ML) class showed a lower prevalence of AR against combined species for moxidectin (54%) compared with abamectin (77%) and ivermectin (87%). Analysis by state revealed higher levels of ML‐resistant Teladorsagia sp. in Tasmania and Western Australia than in other states and ML‐resistant Haemonchus sp. was more frequently detected in New South Wales. CONCLUSION: This compilation of results of FECRTs conducted by Australian parasitology laboratories in 2009–12 showed widespread AR of the common sheep nematodes (Teladorsagia, Trichostrongylus and Haemonchus) to all broad‐spectrum anthelmintics, with the exception of monepantel, whether used singly or in combination.
ISSN:0005-0423
1751-0813
DOI:10.1111/avj.12271